ECM
PFE icon

ExodusPoint Capital Management’s Pfizer PFE Stock Holding History

ExodusPoint Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,700
Closed -$98K – 1875
2024
Q4 		$98K Buy
+3,700
New +$100K ﹤0.01% 1408
2024
Q3 		– Sell
-58,100
Closed -$1.63M – 1982
2024
Q2 		$1.63M Buy
+58,100
New +$1.6M 0.01% 856
2020
Q4 		– Sell
-263,500
Closed -$9.2M – 2288
2020
Q3 		$9.2M Buy
+263,500
New +$9.24M 0.18% 97

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ExodusPoint Capital Management's PFE Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 816,068 shares — an estimated $22.9M sold.

ExodusPoint Capital Management first reported a position in PFE in Q1 2019 and held it in 21 quarters. The position peaked at $47.6M in Q1 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ExodusPoint Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 816,068 Pfizer shares in Q2 2026, an estimated $22.9M.
  • ExodusPoint Capital Management first reported a position in Pfizer in Q1 2019 and held it in 21 quarters.
  • ExodusPoint Capital Management's Pfizer position peaked at $47.6M in Q1 2025.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.